TP53 and lung carcinoma: Although several studies have identified mutations shared by lung cancer drivers in AIS and MIA [[14], [15], [16], [17], [18]], the mutation rate of the three key driver genes (TP53, EGFR and KRAS) varied among these studies, so we compared the mutation profile of these genes in our cohort.